$PRME Income Statement | Understand Stock

$PRME

$4.35 +$0.74 (20.5%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022
Collaboration revenue
Related Party
Nonrelated Party
Total collaboration revenue
Operating expenses:
Research and development
Settlement payment — related party
General and administrative
Total operating expenses
Loss from operations
Other income:
Change in fair value of preferred stock tranche right liability
Change in fair value of anti-dilution obligation
Change in fair value of related party short-term investment
Interest income
Accretion (amortization) of investments
Change in fair value of short-term investment — related party
Other income, net
Total other income, net

Net loss before income taxes
Benefit from income taxes
Net loss attributable to common stockholders, basic
Net loss attributable to common stockholders, diluted
Net loss per share attributable to common stockholders, basic (in dollars per share)
Net loss per share attributable to common stockholders, diluted (in dollars per share)
Weighted-average common shares outstanding, diluted (in shares)
Weighted-average common shares outstanding, basic (in shares)
Comprehensive loss:
Net loss
Accretion of preferred stock to redemption value
Cumulative dividend on preferred stock
Change in unrealized loss on investments, net of tax
Total other comprehensive loss
Comprehensive loss

Comments